DBDorothee B. Bartels

Dorothee B. Bartels

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dorothee B. Bartels has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up

    by Monika Kozieł, Michał Mazurek, Christine Teutsch, Hans-Christoph Diener, Sergio J. Dubner, Jonathan L. Halperin, Chang-Sheng Ma, Kenneth J. Rothman, Axel Brandes, Miney Paquette, et al.

    Background: We aimed to assess the extent to which drug persistence is better with non-vitamin K antagonist oral anticoagulants (NOACs) than vitamin K antagonists (VKAs) in atrial fibrillation (AF) patients and to estimate the difference in therapy persistence depending on NOAC dosing regimen (once daily (QD) vs. twice daily (BID)). Methods: Consecutive patients were followed for 1 year in phase III of the GLORIA-AF registry. Drug persistence was defined as the use of OAC without any discontinuation in >30 days or switching to alternative therapy. Results: Among 21,109 eligible patients in phase III, 17,266 patients who were prescribed OAC at baseline and those who took ≥1 OAC dose were included. The 1-year proportion of patients receiving NOAC and VKA who persisted on treatment was 80% and 75%, respectively. The 1-year persistence with NOACs BID and NOACs QD was 81% and 80%, respectively. Female gender, hypertension, older age, alcohol use, permanent, asymptomatic, and minimally symptomatic AF were associated with better OAC persistence. Region, medication usage predisposing to bleeding, being a current smoker, treatment reimbursement, and proton pump inhibitors were associated with lower OAC persistence. Conclusions: Drug persistence was higher with NOACs (1-year persistence was 80%) than with VKAs (75%). There was little difference in 1-year persistence between NOAC dosing regimens.


  • The Search for Objective Criteria at the Limit of Viability

    by Dorothee B. Bartels, Christian F. Poets

    Background: Defining the limit of viability among very preterm infants remains a difficult issue. A recent study suggested severity of intrauterine growth retardation as a decisive criterion, reporting very poor survival for infants born at ≤28 weeks with birth weight <2nd centile. Objective: To check whether the above criterion can be confirmed in a similar analysis of German data. Methods: Analyses were based on German population-based data from Lower Saxony, including preterm neonates (22–28 weeks) without severe congenital malformations (n = 3,453), born 1991–1999. For the definition of growth retardation postnatal (<3rd, <10th centile) and antenatal (<3rd centile) reference values were used. Results: Depending on the definition used, proportions of growth retarded infants varied considerably (4–16%). Survival rates increased from 0 to 64%, arguing against considering infants <28 weeks’ GA as a homogenous group with regard to their odds for survival. Conclusion: There is an association between severity of growth retardation and VLBW mortality in general, but overinterpreting results from single studies may lead to dangerous conclusions. Data from preterm infants should be stratified by week of gestation.


  • Nosocomial infection in small for gestational age newborns with birth weight <1500 g: a multicentre analysis

    by D. B Bartels, F. Schwab, C. Geffers, C. F Poets, P. Gastmeier

    To investigate whether preterm newborns who are small for gestational age are at increased risk of nosocomial infections and necrotising enterocolitis. The German national surveillance system for nosocomial infection in very low birthweight infants uses the US Centers for Disease Control and Prevention criteria. 2918 newborns (24-28 weeks), born between 2000 and 2004, were selected after application of predefined inclusion criteria to ensure similar proportions of small and appropriate weight for gestational age newborns across gestational age groups. The outcome criterion was at least one episode of nosocomial sepsis, pneumonia or necrotising enterocolitis. Adjusted odds ratios and corresponding 95% CIs were calculated based on general estimating equation models. The study population consisted of 13% (n = 392) small and 87% (n = 2526) appropriate weight for gestational age infants. 33% (n = 950) of the infants experienced at least one episode of sepsis: 42% (n = 163) of small and 31% (n = 787) of appropriate weight for gestational age newborns (adjusted OR 1.41, 95% CI 1.05 to 1.89). Pneumonia was diagnosed in 6% (n = 171) of infants: 8.4% (n = 33) of small and 5.5% (n = 138) of appropriate weight for gestational age newborns (adjusted OR 1.57, 95% CI 1.19 to 5.57). Necrotising enterocolitis was documented in 5.2% (n = 152) of infants: 7.1% (n = 28) of small and 4.9% of (n = 124) appropriate weight for gestational age newborns (adjusted OR 1.20, 95% confidence interval 0.75 to 1.94). Growth-retarded preterm infants seem to be at increased risk of nosocomial infection, irrespective of the responsible pathogen. Future immunological research should elucidate potential causal associations.


  • Obstetrical volume and early neonatal mortality in preterm infants

    by Dorothee B. Bartels, Paul Wenzlaff, Christian F. Poets

    Objective Regionalised perinatal care with antenatal transfer of high risk pregnancies to Level III centres is beneficial. However, levels of care are usually not linked to caseload requirements, which remain a point for discussion. We aimed to investigate the impact of annual delivery volume on early neonatal mortality among very preterm births. Methods All neonates with gestational age 24–30 weeks, born 1991–1999 in Lower Saxony were included into this population-based cohort study (n = 5,083). Large units were defined as caring for more than 1,000 deliveries/year, large NICUs as those with at least 36 annual very low birthweight (Results Within the first week of life, 20.6% of all neonates deceased; 10.2% were stillbirths, 3.7% died in the delivery unit, and 6.7% in the NICU. The crude OR for early neonatal mortality after having been delivered in a small delivery unit (excluding stillbirths) was 1.36 (95%CI 1.04–1.78; adj. OR 1.16 (0.82–1.63)). It increased to 1.96 (1.54–2.48; adj. OR 1.21 (0.86–1.70)) after the inclusion of stillbirths. Conclusion This study has shown a slight, but non-significant association between obstetrical volume and early neonatal mortality. In future studies the impact of caseload on outcome may become more evident when referring to high-risk patients instead of to the overall number of deliveries.


  • Hospital Volume and Neonatal Mortality Among Very Low Birth Weight Infants

    by Dorothee B. Bartels, David Wypij, Paul Wenzlaff, Olaf Dammann, Christian F. Poets

    BACKGROUND. Very low birth weight infants (<1500 g) are at increased mortality risk. Data on the impact of NICU volume are sparse, in comparison with those on the level of care. We hypothesized that neonatal mortality would be higher in small NICUs (1000 births per year) and large NICUs, the adjusted odds ratio was 1.94 for neonates for whom both units were small, 1.75 for those from large delivery units but small neonatal units, and 1.16 for those for whom only the NICU was large. Stratification according to gestational age revealed the greatest impact on mortality for infants of <29 weeks.CONCLUSIONS. Results suggest that creating larger perinatal centers may improve perinatal health care. The volume of the NICU was associated more strongly with 28-day mortality than was the volume of the delivery hospital, and it had the largest impact on survival for infants of <29 weeks.


  • 24 Hospital Volume and Mortality in Preterm Newborns

    by D B Bartels, D Wypij, P Wenzlaff, O O Dammann, C F Poets

  • Brain damage in preterm newborns—What can you do?

    by Dorothee B. Bartels, Olaf Dammann

  • Können Daten aus Qualitätssicherungsprogrammen wie der Peri-/Neonatalerhebung für sekundärepidemiologische Untersuchungen genutzt werden?

    by D. B. Bartels, P. Wenzlaff, C.-F. Poets

    Hintergrund und Fragestellung: Populationsbasierte Analysen bieten die Möglichkeit wichtiger klinisch-epidemiologischer Neuerkenntnisse. Es ist aber problematisch, Daten, die zu einem anderen Zweck erhoben wurden, für wissenschaftliche Fragestellungen zu nutzen. Wir wollten untersuchen, ob Daten der externen Qualitätssicherung genutzt werden können, um das Outcome von „small for gestational age“ (SGA) mit „appropriate size for gestational age“ (AGA) Kindern zu vergleichen. Methoden: Über das Zentrum für Qualitätssicherung an der Ärztekammer Niedersachsen werden perinatale Daten fast aller Geburten in Niedersachsen und neonatale Daten von allen Kindern, die innerhalb der ersten 10 Lebenstage in eine Kinderklinik aufgenommen werden, dokumentiert. Es standen 4126 verbundene perinatale und neonatale Datensätze von Kindern mit einem Geburtsgewicht < 1500 g (very low birthweight, VLBW) aus den Jahren 1991 - 96 zur Verfügung. Nach Überprüfung der Datenvollständigkeit, -repräsentativität und -validität mussten Ein-/Ausschlusskriterien definiert werden, um Verzerrungsquellen zu minimieren und proportionale Anteile von SGA- und AGA-Kindern zu gewährleisten. Würde man alle Mehrlinge in der Studienpopulation belassen, käme es zur Überschätzung mütterlicher Risikofaktoren. Daher wurde nur jeweils eines dieser Geschwister eingeschlossen. Anhand univariabler Mortalitätsanalysen (Kaplan-Meier-Kurven) sollten Auswirkungen von verzerrten Datenbasen demonstriert werden. Ergebnisse: Nach Anwendung der definierten Ausschlusskriterien verblieben 1623 unabhängige (disjunkte) Kinder mit einem Reifealter von 25 - 29 Wochen in der Studienpopulation, 173 SGA- und 1450 AGA-Neugeborene. Die Kaplan-Meier-Kurven der Ausgangspopulation und der definierten Studienpopulation unterschieden sich signifikant. Die Trendanalysen zeigten einen statistisch signifikanten Anstieg (p < 0,05) sowohl des Anteils der VLBW-Kinder (von 0,95 % auf 1,11 %, + 17 %) als auch der SGA-Kinder (von 22,7 % auf 27,4 %, + 21 %) im Beobachtungszeitraum. Schlussfolgerung: Ein detailliert a priori spezifizierter Datenvalidierungsprozess ist erforderlich, um Daten für sekundärepidemiologische Untersuchungen zu nutzen. Die Vernachlässigung dieses essentiellen und arbeitsintensiven Prozesses kann zu erheblichen Verzerrungen führen, was mit ein Grund für die divergierenden Ergebnisse bzgl. des Outcome von SGA- und AGA-VLBW-Kindern sein mag. Background: The aim of this study was to explore whether population-based data from a regional quality control program can be utilized to compare the neonatal outcome of small for gestational age (SGA) and appropriate size for gestational age (AGA) new-borns. Methods: The Center for Quality Management in Health Care maintains perinatal data for almost all births in Lower Saxony (Germany). Neonatal data are collected for all infants admitted to hospital within 10 postnatal days. We evaluated linked perinatal and neonatal datasets of 4126 very low birthweight infants (VLBW; < 1500 g), born in 1991 - 1996. After checking for completeness, representativeness, and validity, exclusion criteria were defined to minimize bias and to yield similar proportions of SGA- and AGA-neonates. Since inclusion of all multiple births would lead to an overestimation of maternal risk factors, one sibling was randomly selected from each set of multiples. Bias arising from not well defined study populations should be shown based on univariable mortality analyses (Kaplan-Meier survival curves). Results: Application of exclusion criteria resulted in a final study population of 1623 independent (disjunctive) new-borns from 25 - 29 weeks gestation, 173 of whom were SGA, 1450 AGA. Kaplan-Meier curves from the initial study population and the well defined study base differed significantly. Trend analysis revealed a significant (p < 0.05) increase in proportions of both VLBW (from 0.95 % in 1991 to 1.11 % in 1996; + 17 %) and SGA infants (from 22.7 % to 27.4 %; + 21 %) within the observational period. A well defined data selection process is necessary if data collected for other purposes are to be used for epidemiological studies. Neglecting this labour-intensive work may be one reason for the varying results on the outcome of SGA and AGA infants.